within Pharmacolibrary.Drugs.V_Various.V03A_AllOtherTherapeuticProducts.V03AF03_CalciumFolinate;

model CalciumFolinate
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 3.4166666666666664e-06,
    adminDuration = 600,
    adminMass = 25 / 1000000,
    adminCount = 1,
    Vd = 0.0072,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.009,
    k12 = 8.583333333333333e-06,
    k21 = 8.583333333333333e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>CalciumFolinate</td></tr><tr><td>ATC code:</td><td>V03AF03</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>25</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>7.2</td><td>L</td></tr>
    <tr><td>clearance:</td><td>205</td><td>ml/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Calcium folinate (leucovorin calcium) is a medication used to reduce the toxic effects of folic acid antagonists such as methotrexate. It is also used in combination with 5-fluorouracil in the treatment of colorectal cancer. Calcium folinate is approved and widely used today as a rescue agent in chemotherapy protocols.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.V.V03AF03 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end CalciumFolinate;
